Taiwanese Dermatological Association consensus for the management of atopic dermatitis

Chu, Chia-Yu; Lee, Chi−Hung; Shih, I‐Hsin; Chen, Hsiu‐Chin; Huang, Po‐Han; Yang, Chin‐Yi; Wang, Wen-Jen; Chen, Yi–Ju; Sheu, Hamm Ming; Wang, Weiming; Lee, William R.; Lo, Yuan-Hsin; Dai, Yue; Wang, Lifang; Tsai, Tsen‐Fang; Yang, Chih‐Hsun

doi:10.1016/j.dsi.2015.06.004

Cited by 17 publications

(41 citation statements)

References 78 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Individual countries have incorporated specific alterations to the standard treatment regimen. For example, in Taiwan, the effectiveness of wet‐wrap therapy may be limited because of the humid climate of the country . Treatment in Taiwan and other countries may also be influenced by steroid phobia among patients .…”

Section: Managementmentioning

confidence: 99%

“…However, the immunosuppressant cyclosporin was added to Japanese health insurance in 2008, prompting its inclusion in the treatment guidelines for adult patients with severe and recalcitrant AD . Although cyclosporin is often not approved for treatment of AD in Asian countries, such as in Taiwan, it is often recommended for refractory AD . In India, cyclosporin has been used, but the country does not have standard guidelines for practitioners to follow regarding its use, and therapy is often individualized according to the knowledge of the physician and the comfort level of the patient .…”

Section: Managementmentioning

confidence: 99%

See 1 more Smart Citation

Burden of atopic dermatitis in Asia

Tsai

Rajagopalan

Chu

et al. 2019

The Journal of Dermatology

View full text Add to dashboard Cite

Atopic dermatitis is a chronic, inflammatory skin disease characterized by intense pruritus and eczematous lesions. It is considered one of the most common chronic conditions, with an estimated global prevalence of nearly 230 million. As in the rest of the world, prevalence of atopic dermatitis has been increasing in Asian countries over the last few decades. This increased prevalence in Asian countries has been attributed to factors such as rapid urbanization, increasingly Westernized lifestyles, and improved standards of living and education. As a result, it is important to understand the increasing burden of disease in Asian countries and the differences between the countries in terms of epidemiology, diagnostic criteria, management, quality of life and economic burden.

show abstract

Section: Managementmentioning

confidence: 99%

Section: Managementmentioning

confidence: 99%

Burden of atopic dermatitis in Asia

Tsai

Rajagopalan

Chu

et al. 2019

The Journal of Dermatology

View full text Add to dashboard Cite

show abstract

“…Compared to topical steroids, there is a lack of recommendations for TCI dose and frequency. The U.S., U.K., South African, Taiwanese, and Japanese guidelines recommend combination therapy consisting of TCI plus TCS . The U.S. guidelines state that TCS and TCI can be combined in multiple ways.…”

Section: Resultsmentioning

confidence: 99%

“…In contrast to the TCS guidelines, none of the TCI guidelines recommend blood monitoring. All guidelines state that there is currently no direct evidence to support the claim that TCI use increases risk for malignancy . Table includes a summary of the international guidelines for TCI use in AD.…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

A comparison of international management guidelines for atopic dermatitis

LePoidevin

Lee

Shi

2018

Pediatric Dermatology

View full text Add to dashboard Cite

Background/Objectives Atopic dermatitis (AD) is a chronic condition that is predominantly found in pediatric patients and commonly presents therapeutic challenges. The management of AD encompasses a variety of factors, and the pillars of optimal management revolve around skin barrier repair and antiinflammatory, antimicrobial, and antipruritic treatment. AD management guidelines exist in various geographic regions globally. The purpose of this review was to compare international guidelines to highlight the similarities and variances among populations and skin types. Comparisons were made for recommendations regarding moisturization, bathing, wet wrap therapy, topical corticosteroids, topical calcineurin inhibitors, antihistamines, antipruritics, antibiotics, systemic immunosuppressants, and biologics. Methods A literature search of the PubMed, EMBASE, and MEDLINE databases was performed for published guidelines in each geographic region. Inclusion criteria included publications available in English that were established by a dermatological association or group including dermatologists, pertained to the treatment of AD in humans, were the most recent guidelines available that were published between 2007 and 2018, and included comprehensive treatment recommendations. Results Publications from Europe, North America, Asia, the Asia‐Pacific region, Australia, and Africa were reviewed, encompassing 14 guidelines. Notable diversity exists across these guidelines regarding recommendations for moisturization and bathing, as well as topical and systemic therapies for AD. Conclusions Due to the heterogeneity of the disease and regional treatment accessibility, complete standardization of AD management guidelines may be difficult. Nevertheless, more consensus on management guidelines is needed, and recommendations should be updated as new treatment modalities become available.

show abstract

Treatments for Childhood Atopic Dermatitis: an Update on Emerging Therapies

Chu

2020

Clinic Rev Allerg Immunol

View full text Add to dashboard Cite

Taiwanese Dermatological Association consensus for the management of atopic dermatitis

Cited by 17 publications

References 78 publications

Burden of atopic dermatitis in Asia

Burden of atopic dermatitis in Asia

A comparison of international management guidelines for atopic dermatitis

Treatments for Childhood Atopic Dermatitis: an Update on Emerging Therapies

Contact Info

Product

Resources

About